Piecing the puzzle together: ACCORDing to whom?

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 4, 2008, Pages 1161-1163

  Hirsch, Irl B ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

DRUG EFFECT; DRUG USE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS;

EID: 42049108626     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-0332     Document Type: Note

References (10)

1. Diabetes Control and Complications Trial Research Group 1993 The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus N Engl J Med 329:977-986
2. U.K. Prospective Diabetes Study Group 1998 Intensive blood-glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) 1998 Lancet 352:837-853
3. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M 1995 Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with noninsulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28:103-117
4. Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, Skene AM, Tan MH, Lefèbvre PJ, Murray GD, Standl E, Wilcox RG, Wilhelmsen L, Betteridge J, Birkeland K, Golay A, Heine RJ, Korányi L, Laakso M, Mokán M, Norkus A, Pirags V, Podar T, Scheen A, Scherbaum W, Schernthaner G, Schmitz O, Skrha J, Smith U, Taton J; PROactive Investigators 2005 Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone ClinicalTrial In macroVascular Events): a randomized controlled trial. Lancet 366:1279-1289
5. Gaede P, Lund-Andersen H, Parving HH, Pedersen O 2008 Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358:580-591
6. Gaede P, Vedel P, Larsen N, Jensen GVH, Parving HH, Pedersen O 2003 Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383-393
7. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group 2005 Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643-2653
8. 2008 Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: http://www.nhlbi.nih.gov/health/prof/heart/other/accord/ (accessed February 9, 2008) Washington, DC: Department of Health and Human Services
9. Chantelau E, Kohner EM 1997 Why some cases of retinopathy worsen when diabetic control improves. BMJ 315:1105-1106
10. Kovatchev BP, Otto E, Cox D, Gonder-Frederick L, Clarke W 2006 Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care 29:2433-2438